BJ
PETX

BlackRock Japan’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlackRock Japan’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
528
– – ﹤0.01% 1272
2016
Q3 		$5K Buy
+528
New +$4.38K ﹤0.01% 1261
2015
Q2 		– Sell
-321
Closed -$5K – 1434
2015
Q1 		$5K Buy
+321
New +$5.71K ﹤0.01% 1278

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's PETX Position: Q4 2016 in Review

BlackRock Japan held its Aratana Therapeutics, Inc. (PETX) position steady in Q4 2016 at 528 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

BlackRock Japan first reported a position in PETX in Q1 2015 and has held it in 3 quarters since. The position peaked at $5K in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • BlackRock Japan held 528 shares of Aratana Therapeutics, Inc. worth $4K as of Q4 2016.
  • BlackRock Japan left its Aratana Therapeutics, Inc. share count unchanged in Q4 2016.
  • Aratana Therapeutics, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1272 holding.
  • BlackRock Japan first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and has held it in 3 quarters since.
  • BlackRock Japan's Aratana Therapeutics, Inc. position peaked at $5K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.